Mylan stock drops 3% after wipeout of a second quarter
August 08, 2018 at 12:59 PM EDT
Chief Executive Heather Bresch, who became the poster child for pharmaceutical villainy over EpiPen price hikes in 2016, also critiqued the U.S. drug pricing system.
